dabigatran has been researched along with Blood Loss, Surgical in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (2.78) | 29.6817 |
2010's | 32 (88.89) | 24.3611 |
2020's | 3 (8.33) | 2.80 |
Authors | Studies |
---|---|
Elsaesser, A; Glund, S; Kreuzer, J; Levy, JH; Pollack, CV; Reilly, PA; Sellke, FW; van Ryn, J; Weitz, JI | 1 |
Barequet, IS; Bourla, N; Moisseiev, J; Salomon, O; Tamarin, I; Zehavi-Dorin, T | 1 |
Goya, M; Hirao, K; Kawabata, M; Maeda, S; Sasano, T; Takahashi, Y; Yagishita, A | 1 |
Caprini, JA; Clark, NP; Douketis, J; Kaplovitch, E; Li, N; MacDougall, K; Schulman, S; Spyropoulos, AC; Tafur, AJ | 1 |
Ali, M; Gunasekaran, K; Kaatz, S; Lavender, R; Mahan, CE; Nakhle, A; Paje, DG | 1 |
Chen, HM; Chou, PC; Chua, SK; Lee, CW; Li, YH; Liao, PC; Lin, HJ; Lin, MJ; Tsai, LK; Yang, YP; Yeh, JT | 1 |
Calabria, S; Dondi, L; Forcesi, E; Maggioni, AP; Martini, N; Pedrini, A | 1 |
Andrade, LAP; Andrade, MQS; Andrade, MVS; Bispo, AF; Feitosa, GS; Feitosa-Filho, GS; Freitas, LA | 1 |
Dibiasi, C; Gratz, J; Wiegele, M | 1 |
Castillo, J; de Andrés, J; Ferrandis, R; Gomar, C; Gómez-Luque, A; Hidalgo, F; Llau, JV; Torres, LM | 1 |
Bazargan, A; Douglas, G; McKenzie, JL | 1 |
Kalus, JS | 1 |
John, A; Michel, MS | 1 |
Curnow, J; Joseph, J; McLintock, C; McRae, S; Nandurkar, H; Tran, H; Wood, P; Young, L | 1 |
Awad, NI; Brunetti, L; Juurlink, DN | 1 |
Brueckmann, M; Connolly, SJ; Douketis, JD; Eikelboom, JW; Ezekowitz, MD; Fraessdorf, M; Healey, JS; Noack, H; Oldgren, J; Reilly, P; Spyropoulos, AC; Wallentin, L | 1 |
Chatelain, B; Dincq, AS; Dogné, JM; Douxfils, J; Gourdin, M; Hjemdahl, P; Lessire, S; Mullier, F; Pohanka, A; Rönquist-Nii, Y | 1 |
Pottegård, A; Rasmussen, LE; Viberg, BL | 1 |
Bernstein, R; Dubiel, R; Eikelboom, J; Glund, S; Huisman, MV; Hylek, E; Kam, CW; Kamphuisen, PW; Kreuzer, J; Levy, JH; Pollack, CV; Reilly, PA; Sellke, F; Stangier, J; Steiner, T; Wang, B; Weitz, JI | 1 |
Smith, LL | 1 |
Blum, RA; Lindfield, D | 1 |
Pollack, CV | 1 |
Pasechnik, IN | 1 |
Bischoff, M | 1 |
Sié, P | 1 |
Gerstrøm, G; Nybo, M; Rosenberg, L | 1 |
Caldwell, SH; Intagliata, NM; Maitland, H; Pellitier, S | 1 |
Buerke, M; Hoffmeister, HM | 1 |
Byron, M; Gavozdea-Barna, M; Gulseth, MP; Hellwig, T; Zochert, S | 1 |
Conard, J; Horellou, MH; Samama, MM | 1 |
Matziolis, D; Matziolis, G; Perka, C | 1 |
Clemens, A; Dahl, OE; Eriksson, BI; Kurth, AA; Noack, H; Rosencher, N | 1 |
Dieterichs, C; Gaudu, T; Geck, M; Stokes, J; Truumees, E | 1 |
Avezum, A; Connolly, SJ; Douketis, J; Eikelboom, J; Ezekowitz, M; Healey, JS; Heidbuchel, H; Heidbuchle, H; Oldgren, J; Reilly, P; Themeles, E; Wallentin, L; Yang, S; Yusuf, S | 1 |
Haas, S; Kreutz, R; Llau, J; Norrving, B; Turpie, AG | 1 |
Martin, EN; Money, SR; Shamoun, FE | 1 |
9 review(s) available for dabigatran and Blood Loss, Surgical
Article | Year |
---|---|
Management of Elective Surgery and Emergent Bleeding with Direct Oral Anticoagulants.
Topics: Administration, Oral; Antibodies, Monoclonal, Humanized; Anticoagulants; Antidotes; Antithrombins; Benzamides; Blood Loss, Surgical; Dabigatran; Deprescriptions; Elective Surgical Procedures; Factor Xa; Factor Xa Inhibitors; Hemorrhage; Humans; Practice Guidelines as Topic; Pyrazoles; Pyridines; Pyridones; Recombinant Proteins; Rivaroxaban; Thiazoles | 2017 |
[Recommendations on use of direct oral anticoagulants in the perioperative period].
Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Loss, Surgical; Dabigatran; Humans; Morpholines; Perioperative Care; Postoperative Hemorrhage; Practice Guidelines as Topic; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Venous Thromboembolism; Withholding Treatment | 2012 |
Perioperative management of anticoagulation in elective surgery.
Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Blood Loss, Surgical; Cardiovascular Diseases; Clopidogrel; Dabigatran; Elective Surgical Procedures; Humans; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Assessment; Thromboembolism; Ticlopidine; Withholding Treatment | 2013 |
Enhanced elimination of dabigatran through extracorporeal methods.
Topics: Antithrombins; Biological Availability; Blood Loss, Surgical; Contraindications; Dabigatran; Drug Overdose; Emergency Medical Services; Evidence-Based Medicine; Hemodiafiltration; Hemorrhage; Humans; Renal Elimination; Tissue Distribution; Up-Regulation | 2015 |
Spotlight on idarucizumab and its potential for the reversal of anticoagulant effects of dabigatran.
Topics: Administration, Intravenous; Administration, Oral; Animals; Antibodies, Monoclonal, Humanized; Antidotes; Antithrombins; Blood Coagulation; Blood Coagulation Tests; Blood Loss, Surgical; Dabigatran; Drug Monitoring; Hemorrhage; Humans; Postoperative Hemorrhage; Risk Factors; Treatment Outcome | 2016 |
[Management of NOAK administration during invasive or surgical interventions : When and how to pause and when to restart?]
Topics: Administration, Oral; Antibodies, Monoclonal, Humanized; Anticoagulants; Blood Loss, Surgical; Dabigatran; Drug Interactions; Half-Life; Humans; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Surgical Procedures, Operative; Thiazoles; Thromboembolism; Vitamin K | 2017 |
Thromboprophylaxis in patients older than 75 years or with moderate renal impairment undergoing knee or hip replacement surgery [corrected].
Topics: Aged; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; Blood Loss, Surgical; Dabigatran; Double-Blind Method; Enoxaparin; Fibrinolytic Agents; Humans; Prospective Studies; Randomized Controlled Trials as Topic; Renal Insufficiency; Venous Thromboembolism | 2012 |
Management consensus guidance for the use of rivaroxaban--an oral, direct factor Xa inhibitor.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Loss, Surgical; Clinical Trials as Topic; Dabigatran; Factor Xa Inhibitors; Female; Humans; Male; Morpholines; Practice Guidelines as Topic; Pregnancy; Rivaroxaban; Stroke; Thiophenes; Venous Thromboembolism; Venous Thrombosis; Warfarin | 2012 |
The novel anticoagulants: the surgeons' prospective.
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Loss, Surgical; Clinical Trials as Topic; Dabigatran; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Surgical Procedures, Operative; Thiazoles; Thiophenes; Venous Thromboembolism; Warfarin | 2013 |
3 trial(s) available for dabigatran and Blood Loss, Surgical
Article | Year |
---|---|
Design and rationale for RE-VERSE AD: A phase 3 study of idarucizumab, a specific reversal agent for dabigatran.
Topics: Antibodies, Monoclonal, Humanized; Antithrombins; Blood Coagulation; Blood Coagulation Tests; Blood Loss, Surgical; Clinical Protocols; Coagulants; Dabigatran; Hemorrhage; Humans; Research Design; Treatment Outcome | 2015 |
[The first antidote is available].
Topics: Antibodies, Monoclonal, Humanized; Blood Loss, Surgical; Dabigatran; Humans; Infusions, Intravenous | 2016 |
Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial.
Topics: Aged; Aged, 80 and over; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Loss, Surgical; Brain Ischemia; Cardiac Pacing, Artificial; Cataract Extraction; Dabigatran; Female; Follow-Up Studies; Hemorrhage; Humans; Incidence; Male; Middle Aged; Postoperative Complications; Risk Factors; Stroke; Thromboembolism; Warfarin | 2012 |
24 other study(ies) available for dabigatran and Blood Loss, Surgical
Article | Year |
---|---|
Dabigatran Reversal With Idarucizumab in Patients Requiring Urgent Surgery: A Subanalysis of the RE-VERSE AD Study.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antithrombins; Blood Coagulation; Blood Loss, Surgical; Dabigatran; Emergencies; Female; Hemorrhage; Humans; Male; Middle Aged; Prospective Studies; Surgical Procedures, Operative | 2021 |
Safety of cataract surgery in patients treated with the new oral anticoagulants (NOACs).
Topics: Administration, Oral; Aged; Aged, 80 and over; Antithrombins; Blood Loss, Surgical; Dabigatran; Eye Hemorrhage; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Incidence; Israel; Male; Middle Aged; Phacoemulsification; Postoperative Hemorrhage; Prospective Studies; Pyrazoles; Pyridones; Rivaroxaban; Thromboembolism | 2019 |
A Survey of Direct Oral Anticoagulant Cessation in General Surgery and Outcomes in Patients with Nonvalvular Atrial Fibrillation.
Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Blood Loss, Surgical; Carotid Artery Diseases; Cerebral Infarction; Dabigatran; Digestive System Surgical Procedures; Elective Surgical Procedures; Embolism; Endoscopy; Factor Xa Inhibitors; Female; Humans; Male; Myocardial Infarction; Orthopedic Procedures; Perioperative Care; Postoperative Complications; Postoperative Hemorrhage; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Thiazoles; Thromboembolism; Urologic Surgical Procedures; Vascular Surgical Procedures | 2020 |
Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation Study.
Topics: Aged; Atrial Fibrillation; Blood Loss, Surgical; Dabigatran; Elective Surgical Procedures; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Medication Therapy Management; Perioperative Care; Pyrazoles; Pyridones; Risk Adjustment; Rivaroxaban; Stroke | 2020 |
Real-World Experience with Idarucizumab to Reverse Anticoagulant Effect in Dabigatran-Treated Patients: Report of 11 Cases from Taiwan.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antithrombins; Blood Coagulation; Blood Loss, Surgical; Dabigatran; Evidence-Based Medicine; Female; Hemorrhage; Humans; Male; Risk Factors; Severity of Illness Index; Taiwan | 2018 |
Target Population of Non-deferrable Surgery and Uncontrolled Severe Bleeding Related to Dabigatran.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antidotes; Antithrombins; Blood Coagulation; Blood Loss, Surgical; Clinical Decision-Making; Cost-Benefit Analysis; Dabigatran; Databases, Factual; Drug Costs; Female; Hospital Costs; Humans; Italy; Male; Middle Aged; Patient Selection; Postoperative Hemorrhage; Retrospective Studies; Young Adult | 2018 |
Evaluation of the Bleeding Intensity of Patients Anticoagulated with Warfarin or Dabigatran Undergoing Dental Procedures.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Bleeding Time; Blood Loss, Surgical; Dabigatran; Female; Humans; Male; Middle Aged; Prospective Studies; Reference Values; Risk Factors; Statistics, Nonparametric; Time Factors; Tooth Extraction; Treatment Outcome; Warfarin | 2018 |
Orthotopic liver transplantation in a patient receiving apixaban for portal vein thrombosis.
Topics: Aged; Blood Loss, Surgical; Carcinoma, Hepatocellular; Dabigatran; Humans; Infusions, Intravenous; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Mesenteric Vascular Occlusion; Mesenteric Veins; Pyrazoles; Pyridones; Risk Assessment; Thromboembolism; Tranexamic Acid; Venous Thrombosis | 2019 |
Pharmacologic interventions for reversing the effects of oral anticoagulants.
Topics: Administration, Oral; Anticoagulants; Antifibrinolytic Agents; Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Blood Loss, Surgical; Dabigatran; Drug Therapy, Combination; Emergencies; Hemorrhage; Humans; International Normalized Ratio; Morpholines; Plasma; Pyrazoles; Pyridones; Rivaroxaban; Surgical Procedures, Operative; Thiophenes; Thromboembolism; Treatment Outcome; Vitamin K 1; Warfarin | 2013 |
[Rivaroxaban, dabigatran and apixaban: new anticoagulants in operative urology].
Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Loss, Surgical; Dabigatran; Humans; Morpholines; Postoperative Hemorrhage; Premedication; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Treatment Outcome; Urologic Surgical Procedures | 2014 |
New oral anticoagulants: a practical guide on prescription, laboratory testing and peri-procedural/bleeding management. Australasian Society of Thrombosis and Haemostasis.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation Tests; Blood Loss, Surgical; Contraindications; Dabigatran; Drug Interactions; Drug Monitoring; Drug Substitution; Elective Surgical Procedures; Emergencies; Hematoma, Epidural, Spinal; Hemorrhage; Humans; Kidney Diseases; Liver Diseases; Morpholines; Patient Selection; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Thrombophilia | 2014 |
Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial.
Topics: Adult; Aged; Anticoagulants; Atrial Fibrillation; Blood Loss, Surgical; Dabigatran; Drug Administration Schedule; Elective Surgical Procedures; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Perioperative Care; Postoperative Hemorrhage; Propensity Score; Proportional Hazards Models; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Stroke; Surgical Procedures, Operative; Time Factors; Treatment Outcome; Warfarin | 2015 |
Estimation of dabigatran plasma concentrations in the perioperative setting. An ex vivo study using dedicated coagulation assays.
Topics: Antithrombins; Blood Coagulation Tests; Blood Loss, Surgical; Case-Control Studies; Chromatography, Liquid; Dabigatran; Drug Administration Schedule; Drug Monitoring; Humans; Limit of Detection; Linear Models; Partial Thromboplastin Time; Perioperative Care; Postoperative Hemorrhage; Predictive Value of Tests; Reproducibility of Results; Risk Factors; Tandem Mass Spectrometry; Thrombin Time; Time Factors | 2015 |
[Fatal outcome for a patient in treatment with dabigatran suffering a subtrochanteric femoral fracture].
Topics: Aged, 80 and over; Antithrombins; Atrial Fibrillation; Blood Loss, Surgical; Dabigatran; Fatal Outcome; Female; Hip Fractures; Humans; Radiography; Time-to-Treatment | 2015 |
ISTH 2015 Congress.
Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Arthroscopy; Blood Loss, Surgical; Dabigatran; Factor VIII; Hemophilia A; Humans; Randomized Controlled Trials as Topic; Rivaroxaban; Single-Domain Antibodies; Venous Thromboembolism | 2015 |
Direct oral anticoagulant drugs (DOAC).
Topics: Administration, Oral; Anticoagulants; Antithrombins; Blood Loss, Surgical; Cataract Extraction; Dabigatran; Eye Hemorrhage; Factor Xa Inhibitors; Humans; Pyrazoles; Pyridones; Rivaroxaban; Warfarin | 2016 |
Cardiology Patient Pages: Antidotes for Bleeding Caused by Novel Oral Anticoagulants.
Topics: Administration, Oral; Antibodies, Monoclonal, Humanized; Antithrombins; Blood Loss, Surgical; Cerebral Hemorrhage; Clinical Trials as Topic; Dabigatran; Drug Approval; Emergencies; Factor Xa; Factor Xa Inhibitors; Hemorrhage; Humans; Pyrazoles; Pyridines; Pyridones; Recombinant Proteins; Rivaroxaban; Thiazoles; United States; United States Food and Drug Administration | 2016 |
[The use of new oral anticoagulants in surgery].
Topics: Anticoagulants; Blood Coagulation; Blood Loss, Surgical; Comorbidity; Dabigatran; Drug Interactions; Drug Overdose; Drug Substitution; Humans; Perioperative Period; Postoperative Hemorrhage; Risk Adjustment; Surgical Procedures, Operative | 2016 |
Idarucizumab for Reversal of Dabigatran Prior to Acute Surgery: A Schematic Approach Based on a Case Report.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antithrombins; Atrial Fibrillation; Blood Coagulation; Blood Coagulation Tests; Blood Loss, Surgical; Dabigatran; Humans; Intestinal Obstruction; Male; Postoperative Hemorrhage | 2017 |
Reversal of direct oral anticoagulants for liver transplantation in cirrhosis: A step forward.
Topics: Administration, Intravenous; Administration, Oral; Antibodies, Monoclonal, Humanized; Anticoagulants; Blood Loss, Surgical; Dabigatran; End Stage Liver Disease; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Preoperative Care; Severity of Illness Index; Treatment Outcome; Venous Thrombosis | 2017 |
Successful use of laboratory monitoring to facilitate an invasive procedure for a patient treated with dabigatran.
Topics: Aged, 80 and over; Antithrombins; Atrial Fibrillation; Biomarkers; Blood Coagulation Tests; Blood Loss, Surgical; Dabigatran; Female; Femoral Neck Fractures; Hemiarthroplasty; Humans; Time Factors; Time-to-Treatment; Withholding Treatment | 2017 |
[Pregnancy and venous thromboembolism. North-American and European guidelines. American College of Chest Physicians].
Topics: Abnormalities, Drug-Induced; Adult; Anticoagulants; Benzimidazoles; Blood Loss, Surgical; Cesarean Section; Contraindications; Dabigatran; Europe; Evidence-Based Medicine; Female; Fetus; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Humans; Infant, Newborn; Morpholines; Polysaccharides; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Hematologic; Puerperal Disorders; Pyridines; Rivaroxaban; Societies, Medical; Thiophenes; Thrombophilia; United States; Uterine Hemorrhage; Venous Thromboembolism; Warfarin | 2009 |
Thromboembolism prophylaxis with dabigatran leads to lower perioperative blood loss than with dalteparin in primary knee arthroplasty.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Antithrombin Proteins; Arthroplasty, Replacement, Knee; Benzimidazoles; Blood Loss, Surgical; Case-Control Studies; Dabigatran; Dalteparin; Female; Humans; Male; Middle Aged; Pyridines; Retrospective Studies; Thromboembolism | 2011 |
Epidural hematoma and intraoperative hemorrhage in a spine trauma patient on Pradaxa (dabigatran).
Topics: Aged; Anticoagulants; Benzimidazoles; Blood Loss, Surgical; Blood Transfusion; Dabigatran; Decompression, Surgical; Hematoma, Epidural, Cranial; Humans; Intraoperative Period; Male; Pyridines; Retrospective Studies; Spinal Fractures; Spinal Fusion; Thoracic Vertebrae; Treatment Outcome | 2012 |